Factset League Tables YTD-September

Hey all, just thought it'd be interesting to post the US and Global M&A League Tables for YTD-September from FactSet.

US League Table
USA M&A League Table
Global League Table
Global M&A League Table
Keep in mind that league tables are NOT 100% accurate (aka please don't turn this into another ranking thread). Also, note that the transaction value only includes disclosed transaction values, while total deals includes all announced deals (including undisclosed transaction values).

WSO Elite Modeling Package

  • 6 courses to mastery: Excel, Financial Statement, LBO, M&A, Valuation and DCF
  • Elite instructors from top BB investment banks and private equity megafunds
  • Includes Company DB + Video Library Access (1 year)

Comments (73)

  • Analyst 1 in IB-M&A
Oct 2, 2021 - 11:11am

Thanks for the info, very helpful. Is there anyway to adjust so total deal only includes deals with disclosed transaction terms (so it matches with total transaction value)?

  • Analyst 2 in IB - Gen
Oct 2, 2021 - 11:29am

Global Disclosed M&A

Global M&A league tables with only # of deals with disclosed transaction amounts.

Oct 2, 2021 - 1:30pm

yeah dude you gotta HC that into the excel backup so it ties. or just add "illustrative" to the title. duh.

Hear me now, children, for my occupation is of much import. For 82 years I have been an oil man, a ‘baron’ some have called me. Now what does an oil baron do? The answer - crush your enemies! Grind their bones into dirt! Make them regret that they were ever born! Oil is not for the weak - it is the Earth’s milk, and only the strong may suckle at Mother’s teat!

  • 1
Learn More

300+ video lessons across 6 modeling courses taught by elite practitioners at the top investment banks and private equity funds -- Excel Modeling -- Financial Statement Modeling -- M&A Modeling -- LBO Modeling -- DCF and Valuation Modeling -- ALL INCLUDED + 2 Huge Bonuses.

Learn more
  • Analyst 2 in IB - Gen
Oct 2, 2021 - 11:35am

Moelis does a lot more sponsor advisory than strategic advisory compared to other EBs, and sponsor transactions tend to have undisclosed values a lot more, hence why Moelis's total disclosed value is a lot lower. Looking at the data, only 55% of Moelis's transactions have disclosed values, compared to 62% for Lazard, 69% for Evercore, 72% for PJT, and 83% for CVP and PWP.

  • Analyst 2 in IB - Cov
Oct 2, 2021 - 12:41pm

Both. What really matters is your deal reps and exposure as an analyst (essentially deal count/IB analyst class size could serve as a decent proxy). I can tell you that deal size really doesn't matter that much and doesn't mean a better analyst experience. I'm at an EB that does everything from the $100M sell side to the mega-cap deal, and I've generally found that deals around the $700-$1.5B range have been the most enjoyable deals to work on.

  • Intern in IB-M&A
Oct 2, 2021 - 3:44pm

Moelis usually isn't that high in league tables. Their bread and butter has always been MM to mid-cap sponsor sell-sides, and have always been a volume shop like Jefferies or Lazard doing way more deals than the PJT/CVP-type firms. 

Most Helpful
  • Analyst 2 in IB - Gen
Oct 2, 2021 - 1:47pm

Very interesting, thanks for posting.

- Evercore seems to have solidified its status as "the Goldman of independent advisory firms" 

- Jefferies is killing it, seems like it's solidly established itself below CS in North America over the past couple of years. International presence is still weaker than the BBs though. 

- Allen & Co, Qatalyst, and LionTree are absolutely killing it in TMT

- WF's M&A deal flow still doesn't seem to have picked up compared to the past few years

- Greenhill has seemed to completely dropped off. I don't think they've been in top 50 in league tables since 2018 or so.

  • Analyst 1 in IB - Gen
Oct 4, 2021 - 1:13pm

Wells is a financing bank, and until recently has been very content to stay there. Scharf has been pushing us to gain more M&A share, but that won't happen overnight

  • Intern in IB-M&A
Oct 2, 2021 - 5:14pm

Interesting to see the difference in number of deals between the EBs. You have PJT with 36 deals so far all the way to Rothschild, which may not be an EB in the US but I guess counts as a global EB, with 323 deals.

  • Intern in IB-M&A
Oct 2, 2021 - 5:17pm

Is JPM usually higher than MS? I always thought MS was #2 in terms of transaction volume in the US, but maybe that's outdated.

Oct 5, 2021 - 3:40pm

driven by their balance sheet. they'll provide financing for a deal, do no actual M&A advisory, but ask for M&A credit (and usually give better financing terms for it). so transaction value isn't as good a proxy as revenues if you are looking for a metric that implies deal flow or potential bonus comp.

  • Intern in IB-M&A
Oct 2, 2021 - 5:53pm

Completely off-topic but didn't BofA's IB division drop the ML name in 2019? If so, when will that name change start to reflect in the Industry (aka FactSet stop using BofA ML, people stop shortening BofA to BAML on WSO, etc)? Just curious because I feel like by 2014/15 few people used Wachovia to refer to WF's IBD brand

  • Summer Associate in IB-M&A
Oct 2, 2021 - 5:57pm

I think it is slowly happening. The BAML name is a lot more sticky as BofA's kept it around a lot longer than WF kept Wachovia (I believe WF kept the Wachovia name for only 3 years), but I think there's been a very gradual transition (anecdotally at my BB fewer and fewer of the senior people are calling BofA by Merrill). Give it maybe 5 or more years and I think the BAML name may be gone.

  • Analyst 1 in IB - Cov
Oct 3, 2021 - 8:51am

Could anybody please pull league tables from other sources, eg. Bloomberg, to complement what was already posted?

  • Analyst 2 in IB - Gen
Oct 3, 2021 - 7:09pm

Although it was already well known in Rothschild's case, it's interesting to see Lazard's disparity between their global M&A deal flow vs their U.S. deal flow.

  • Intern in IB-M&A
Oct 3, 2021 - 10:08pm

Just thought it'd be interesting to post these 2007 Mergermarket M&A league tables I found.


2007 Global M&A


2007 US M&A

  • Intern in IB-M&A
Oct 3, 2021 - 10:13pm

Interesting, thanks for posting! Surprising to see how little has changed, with Barc today roughly where Lehman was, and BofA roughly where Merrill was. Did not know that Wachovia was as strong as it was (for some reason I always had the impression Wachovia was where WF roughly is today back then). Interesting that Greenhill completely fell off, and Jeff and Guggenheim really were nowhere pre-GFC.

  • Analyst 2 in IB - Cov
Oct 3, 2021 - 10:25pm

Seems like there was also a much larger distinction between BB and everything else back then. The BB field was pretty tight globally back then, with 1-9th occupied by BBs and all of them above $600B in transaction volume.

  • Analyst 1 in IB-M&A
Oct 3, 2021 - 10:20pm

So looking at the league tables RBC's been a "rising BB" since before the GFC huh?

Oct 4, 2021 - 12:58pm

This was an interesting post. Know a few people who were at Bear Stearns/CIBC back then (had no clue CIBC did fairly well back then honestly, Bear Stearns was a scrappy banker. A former IB analyst (left finance after working at Bear Stearns) said it was a very scrappy bank vs bigger banks. Often let hard workers get to better departments internally vs. hiring external candidates. Heard that although Blackstone M&A often wasn't in the top echelon of banks in M&A fees, it was one of the hardest interviews/positions to land. Their exits were absurd vs. most of the street.

Oct 4, 2021 - 12:34pm

I mean look at vault rankings those 2 are like pretty low and on this site all EBs are deemed more prestigious even though they are top 5 in deal value. I guess its deal value / head that matters. 

  • Associate 1 in IB - ECM
Oct 8, 2021 - 12:59pm

I've never heard too much negative feedback on BAML.  Citi gets a bad rep because they 'self own' somewhat consistently.  Lots of stories about pitches destined to fail, dropped balls, missing out on deals for silly reasons (an MD repeatedly mispronouncing the client's name from one story I've heard).  They also have below-average internal management - it can take months to get approval from finance / HR to replace an analyst who leaves for PE - even when most of a team leaves at the same time (which they've had to deal with).

Also, at least amongst (some of) the junior class, they jokingly call themselves 'Shitty Bank', which comes from the above + the fact that they routinely try to compete with GS/MS/JPM and lose out on mandates.

Bankers aren't usually the happiest bunch, but the Citi guys I've met seem to be some of the least happy - all of the pain of banking, with worse institutional support, and a handicap on exits and comp vs. the banks they consider their peers.

Oct 4, 2021 - 1:20pm

Anonymous Monkey

Hey all, just thought it'd be interesting to post the US and Global M&A League Tables for YTD-September from FactSet.

US League Table

USA M&A League Table

Global League Table

Global M&A League Table

Keep in mind that league tables are NOT 100% accurate (aka please don't turn this into another ranking thread). Also, note that the transaction value only includes disclosed transaction values, while total deals includes all announced deals (including undisclosed transaction values).

Goldman, wins again!

SafariJoe, wins again!
  • Intern in IB - Gen
Oct 6, 2021 - 12:08pm

Goldman had an avg. value of ~$3bln/deal YTD, compared to JPM's ~2.6bln/deal and MS' ~$3.3bln/deal. I think it's honestly fine to divide out the deal value by # of deals; all the top 3 banks hunt for 'whales,' and will be on 90-100% of mega caps. But also, they're all on the ~$100-1b deals -- at least for JPM & GS since those two have the Regional IB & Cross Markets groups to break into the mid-market. To the extent that deal size is influencing anything, it's the placement of the EBs imo. The gap between JP and Citi, for example, is really a lot of deal flow since Citi's average value per deal is about the same ($413,320 / 142 ~= 2.9b) as JPM's.

  • Prospect in IB - Gen
Oct 6, 2021 - 2:02pm

It seems PWP is having a really good year. Interested to hear if people think this is a one-off or if this will be a sustained thing

Oct 6, 2021 - 11:57pm

Sustained, they consistently do more and more deals despite such a small head count. With expected growth it'll be interesting to see what they evolve into.

  • Intern in IB-M&A
Oct 8, 2021 - 2:13pm

As two of the MM firms on the list why aren't Piper Sandler and Houlian Lokey usually brought up as top MM firms compared to William Blair/Baird

Oct 8, 2021 - 2:13pm

Delectus et facilis cumque ipsam rerum. Est nobis ducimus laboriosam nobis nulla ratione. Ipsum optio quaerat labore perspiciatis aut rerum omnis ut. Modi veniam officia qui omnis magni.

Voluptatem ipsum aliquid sunt magnam. Reiciendis et quibusdam sed fuga debitis et. Aut ut itaque explicabo deleniti perspiciatis. Magni quis qui totam dolore.

Molestiae et mollitia est aut perferendis quia vel. Unde saepe corporis nemo. Voluptates ut voluptas dolor eaque illo facere aut et. Expedita adipisci et et molestiae et dolore facere.

  • Intern in HF - Event
Oct 8, 2021 - 2:59pm

Est temporibus eligendi ipsum id vitae modi. Voluptas tempore odio earum aperiam ad quis est blanditiis. Magni iusto illum enim.

Eius enim qui voluptatem labore voluptatum et. Sapiente ea cumque quae voluptatem aut officia. Exercitationem dignissimos velit ea quis. Rem reiciendis consequatur velit aut eos magnam. Velit et dicta laudantium qui.

Numquam in cum dignissimos fugiat eveniet numquam quis. Sint eaque error rerum non eos aliquam assumenda. Voluptatem exercitationem commodi sed pariatur labore. Temporibus officiis eligendi amet fugiat est.

Start Discussion

Total Avg Compensation

November 2021 Investment Banking

  • Director/MD (10) $853
  • Vice President (40) $360
  • Associates (236) $235
  • 2nd Year Analyst (145) $156
  • 3rd+ Year Analyst (34) $154
  • Intern/Summer Associate (107) $146
  • 1st Year Analyst (514) $136
  • Intern/Summer Analyst (394) $84